Volume 72, Issue 1, Pages (July 2007)

Slides:



Advertisements
Similar presentations
Volume 72, Issue 1, Pages (July 2007)
Advertisements

Volume 69, Issue 11, Pages (June 2006)
Kidney stones are common after bariatric surgery
Volume 66, Issue 2, Pages (August 2004)
Volume 63, Issue 3, Pages (March 2003)
Contribution of dietary oxalate to urinary oxalate excretion
Volume 69, Issue 11, Pages (June 2006)
Volume 81, Issue 11, Pages (June 2012)
Volume 69, Issue 5, Pages (March 2006)
Jennifer L. Ennis, John R. Asplin  International Journal of Surgery 
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
A. Evan, J. Lingeman, F.L. Coe, E. Worcester  Kidney International 
Volume 84, Issue 4, Pages (October 2013)
Volume 56, Issue 4, Pages (October 1999)
Y. Wang, X. Chen, Y. Song, B. Caballero, L.J. Cheskin 
Kidney stones are common after bariatric surgery
Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, K. LaPlante, J.R. Asplin 
Volume 73, Issue 5, Pages (March 2008)
Volume 55, Issue 1, Pages (January 1999)
Urinary cystine excretion and capacity in patients with cystinuria
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Volume 65, Issue 5, Pages (May 2004)
Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful  Salvatore Scali, MD, Virendra Patel,
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 66, Issue 2, Pages (August 2004)
A new era in phosphate binder therapy: What are the options?
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 76, Issue 3, Pages (August 2009)
John R. Asplin, Joan H. Parks, Yashushi Nakagawa, Fredric L. Coe, M.D. 
Volume 73, Pages S5-S17 (April 2008)
Spontaneous self-alkalinization in spontaneous tumor lysis syndrome
Volume 70, Issue 12, Pages (December 2006)
Volume 69, Issue 9, Pages (May 2006)
Use of a probioitic to decrease enteric hyperoxaluria
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, A.C. Michalenka, K.L.
Fructose intake as a risk factor for kidney stone disease
Volume 63, Issue 1, Pages (January 2003)
Volume 84, Issue 4, Pages (October 2013)
Recent experience with high-dose intravenous iron administration
Volume 72, Issue 1, Pages 8-10 (July 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 60, Issue 1, Pages (July 2001)
Volume 93, Issue 1, Pages (January 2018)
Volume 78, Issue 11, Pages (December 2010)
Volume 69, Issue 4, Pages (February 2006)
Urinary biomarkers in the early diagnosis of acute kidney injury
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Association of urinary pH with body weight in nephrolithiasis
Differences in Blood Transfusion Trends Between US and UK Centers
Volume 81, Issue 11, Pages (June 2012)
Organ transplantation goes to the movies
Cystinuria subtype and the risk of nephrolithiasis1
H.J. Heller, J.E. Zerwekh, F.A. Gottschalk, C.Y.C. Pak 
Jacob Lemann, Nancy D. Adams, Donald R. Wilz, Luis G. Brenes 
Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, M.D., Walter R. Parker,
Volume 60, Issue 3, Pages (September 2001)
Contribution of dietary oxalate to urinary oxalate excretion
Treatment of the primary hyperoxalurias: A new chapter
Replacing the short ammonium chloride test
Urinalysis in Western culture: A brief history
Volume 69, Issue 11, Pages (June 2006)
Volume 70, Issue 5, Pages (September 2006)
Joan H. Parks, Elaine M. Worcester, R. Corey O'Connor, Fredric L. Coe 
Volume 62, Issue 5, (November 2002)
The International Pediatric Peritonitis Registry: Starting to walk
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Volume 69, Issue 11, Pages (June 2006)
Volume 63, Issue 3, Pages (March 2003)
A. Lauschke, U.K.M. Teichgräber, U. Frei, K.-U. Eckardt 
Presentation transcript:

Volume 72, Issue 1, Pages 100-107 (July 2007) Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery  M.K. Sinha, M.L. Collazo-Clavell, A. Rule, D.S. Milliner, W. Nelson, M.G. Sarr, R. Kumar, J.C. Lieske  Kidney International  Volume 72, Issue 1, Pages 100-107 (July 2007) DOI: 10.1038/sj.ki.5002194 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Urinary chemistries in patients presenting with nephrolithiasis after RYGB. Twenty-four urine values for volume, pH, citrate, calcium, oxalate, and creatinine clearance are depicted with superimposed box plots for each analyte. Patients are divided into those undergoing distal and standard RYGB. Horizontal lines indicate upper (oxalate, calcium, CaOx SS) or lower (citrate) limits of reference ranges for selected analytes. Not all patients had sufficient data to calculate CaOx SS. Kidney International 2007 72, 100-107DOI: (10.1038/sj.ki.5002194) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Urinary chemistries in patients presenting with nephrolithiasis after RYGB divided into those without (No) or with (Yes) a prior history of stones. Twenty-four urine values for volume, pH, citrate, oxalate, calcium, and CaOx SS are depicted with superimposed box plots for each analyte. Horizontal lines indicate upper (oxalate, calcium, CaOx SS) or lower (citrate) limits of reference ranges for selected analytes. Patients are divided into those without stones before RYGB and those with antecedent stones. Among those with a prior history of stones, possible trends were for higher mean citrate (P=0.22) and calcium (P=0.18) excretions and lower oxalate excretions (P=0.10), although none reached statistical significance. Urinary CaOx SS were equally high in both groups. Not all patients had sufficient data to calculate CaOx SS. Kidney International 2007 72, 100-107DOI: (10.1038/sj.ki.5002194) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Oxalate excretion among patients that presented with nephrolithiasis as a function of time since RYGB. Urinary oxalate excretion was low in many patients early after RYGB (6/8 <6 months postoperative in the left panel), whereas CaOx SS was in general high at all time points after the procedure (right panel). Note log scale on the x axis; vertical line is at 6 months (0.5 years). Not all patients had sufficient data to calculate CaOx SS. Urinary oxalate levels were elevated in a greater percentage of patients that presented with stones >6 months after RYGB (15/23) as compared with those <6 months after RYGB (2/8), with overall higher oxalate excretions (0.74±0.42 vs 0.44±0.24 mM/24 h; P<0.05). Kidney International 2007 72, 100-107DOI: (10.1038/sj.ki.5002194) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Urinary chemistries among patients that presented with nephrolithiasis after RYGB as a function of time after RYGB. Twenty-four urine values for volume, pH, citrate, calcium, oxalate, and creatinine clearance are depicted with superimposed box plots for each analyte. Horizontal lines indicate upper (oxalate, calcium, CaOx SS) or lower (citrate) limits of reference ranges for selected analytes. Patients were divided in those less than 6 months vs greater than 6 months postoperative. Although oxalate levels were lower in the early postoperative group, urinary CaOx SS were equally high in both groups. Horizontal lines indicate limits of reference range for individual analytes. Not all patients had sufficient data to calculate CaOx SS. Kidney International 2007 72, 100-107DOI: (10.1038/sj.ki.5002194) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Changes in urinary oxalate and CaOx SS in a random sample of patients both before and after RYGB. Oxalate was increased above the upper limit of the reference range (horizontal line, 0.46 mM/ 24 h) in two out of 20 patients preprocedure and in seven out of 13 at 12 months. At 12 months, all but one patient had a CaOx SS above the reference mean of 1.77 (horizontal line). P=0.009 for comparison of CaOx SS between baseline and 12 months groups. Kidney International 2007 72, 100-107DOI: (10.1038/sj.ki.5002194) Copyright © 2007 International Society of Nephrology Terms and Conditions